couter

ALNFL.PANFL Biosciences S.A.

Dec 15, 2026 — Phase 3 Strategic Partnership Update (NFL-101)
Chart by TradingView

The schedule

  • Tue15Dec

    Window for management to secure a pharma partner to fund Phase 3 trials for NFL-101.

  • Mon4Jan

    Expected authorization of the Clinical Trial Application for NFL-301 in alcohol addiction.

  • Sun31Jan
  • Mon15Feb

    High probability of equity financing if non-dilutive capital or partnerships fail to materialize.

  • Thu15Apr

    Full-year earnings report detailing the clinical pathway for NFL-102 and NFL-301.

  • Sun2May
  • Sun1Aug
  • Sun31Oct

Past

  • Thu22Oct

    Release of half-year 2026 financial results, focusing heavily on operational cash burn.